An assembly plant worker receives the Pfizer-BioNTech vaccine on a bus in Ciudad Juarez, Mexico. A vaccination site in a movie theater in San Juan City, Manila (Philippines). The Natural History Museum in New York City (USA) was requisitioned as a COVID-19 vaccination site. A health worker administers the AstraZeneca vaccine at the municipal theater in Rio de Janeiro (Brazil). A woman is vaccinated with Sinovac Biotech’s CoronaVac vaccine in a movie theater in San Juan (Philippines). A person is vaccinated against QazCovid-in at a shopping and entertainment center in Almaty (Kazakhstan). Kazakhstan uses the QazCovid-in vaccine, also known as QazVac, developed by the country, for mass injection. People wait in front of FC Barcelona’s Camp Nou stadium in Barcelona (Spain) to be vaccinated against COVID-19. Teachers wait in line to receive the CanSino vaccine (China) outside the military base in Ciudad Juarez (Mexico). A woman is vaccinated at a bar in Tel Aviv (Israel). Previously, the Tel Aviv government had an initiative to provide free drinks at bars to citizens who were vaccinated. A woman is vaccinated at a mobile vaccination site in Northumberland park as the number of new mutated COVID-19 cases increases in Shiremoor, North Tyneside, England. A vaccination site at Suvarnabhumi Airport in Bangkok (Thailand). People wait for vaccinations in the Usce shopping center (Belgrade, Serbia). Here, the first 100 injectors will receive a voucher worth 3,000 dinars (equivalent to $30.74). France’s national cycling team trains as people wait for the Pfizer-BioNTech vaccine at an indoor stadium in Paris (France). A factory employee is vaccinated with Pfizer-BioNTech on a bus in Ciudad Juarez (Mexico). Vaccination point at Coney Island subway station in Brooklyn, New York (USA). Vacci’Bus, a bus converted into a vaccination and counseling center, travels through remote villages near Reims (France) to bring COVID-19 vaccines to the elderly. Vaccination site inside Salisbury Cathedral, in Salisbury (England). A man is vaccinated against COVID-19 in the remote mountain village of Ljevista, in the municipality of Kolasin (Montenegro). Health workers prepare before administering AstraZeneca vaccine to a riverside community in Manaus (Brazil). A person watches after injection at Saint Mark’s Episcopal Church, Seattle, Washington (USA). Customers dine at a restaurant where people are injecting China’s Sinopharm vaccine in Kragujevac (Serbia). Biblioteka kod Milutina restaurant claims to be giving away a free meal to anyone who decides to get vaccinated. People wait in line to get vaccinated at the Grand Central Station Terminal in Manhattan (New York). A resident is vaccinated with AstraZeneca at home amid flooding on the Solimoes River in Anama, Brazil. A patient receives the AstraZeneca vaccine at the clinic of Dr Claudia Schramm in Maintal (Germany). A bus is used as a mobile vaccination site in Thamesmead, London (UK). A Venetian gets vaccinated in a traditional ‘vaporetto’. This is a ferry commonly used for public transport in Venice (Italy). Health professionals come to vaccinate a farming community in Mecca (California). A woman gives Sputnik V vaccine at a mobile vaccination station on a bus in Simferopol (Crimea, Russia). A rice miller is injected with a dose of COVISHIELD during a vaccination campaign in Bavla village on the outskirts of Ahmedabad, India. Photo: Reuters

People wait for their turn to get vaccinated against COVID-19 in Beijing. Photo: AP According to CNBC, within just 5 days of May, China injected 100 million doses of the COVID-19 vaccine to its people. Health officials hope to be able to vaccinate 80% of its 1.4 billion population by the end of 2021. As of June 2, China has injected a total of over 704 million doses of vaccine, of which half were administered in May. The total number of doses of COVID-19 vaccine that China has given to the population accounts for about one-third in one. ,9 billion doses of vaccine are distributed globally. The call to vaccinate is from all walks of life. Companies inject workers, schools urge students and teachers to immunize, local authorities urge people to vaccinate. According to Our World in Data, in 7 days, China is injecting an average of 19 million doses per day. With a population a quarter of China’s, the US only injected 3.4 million doses / day in April – when the vaccination campaign was operating at full speed. A medical worker administers a COVID-19 vaccine at a vaccination site in Shanghai, China. Photo: THX/VNA On May 30, Zhong Nanshan, the head of an expert group of the National Health Commission of China, said that 40% of the Chinese population has been vaccinated with at least one dose, and the government’s goal is to fully immunize all patients. this number at the end of June. In the capital Beijing, 87% of people have received at least one dose of the COVID-19 vaccine. Vaccination in Beijing is easy because there are hundreds of vaccination service points throughout the city. Vaccination buses are parked right in crowded areas such as city centers and commercial centers. However, vaccination in other areas is not as easy as in the capital. Ms. Zhou Hongxia, a resident of Lanzhou, Gansu province, said: “I started waiting in line for the injection at 9am and didn’t get the injection until 6pm. It’s tiring. When I returned, there were still people waiting.” Ms. Zhou’s husband couldn’t even schedule a vaccination. On May 31, government officials said they were working to ensure the supply of COVID-19 vaccine is distributed more evenly. Not only focusing on inoculating people in the country, China also injects its citizens abroad when donating vaccines to Thailand, part of which is used to vaccinate the Chinese before giving them to Thai people. Globally, China has injected more than 500,000 citizens abroad. Before the domestic vaccination campaign accelerated in recent weeks, many Chinese people were in no hurry to get vaccinated because China had almost no cases in the community thanks to tight border controls and mandatory isolation. Recently, China has appeared many small clusters of infection and is suppressing the cluster in Guangzhou. According to analysts, despite the uneven distribution of COVID-19 vaccines, Chinese manufacturers have hardly had problems with the scale of production. Both companies that produce most of the COVID-19 vaccines being used in China, Sinovac and Sinopharm, have drastically increased production, built new factories and converted existing factories to produce COVID-19 vaccines. . Vaccines of Sinovac Biotech (China) at a vaccination center in Bangkok, Thailand on May 12, 2021. Photo: THX/VNA Vaccines from Sinovac and one from Sinopharm have been approved for emergency use by the World Health Organization. “Where in the world can match China in terms of construction speed? How long does it take China to build field hospitals? Just a few days.” Sinovac said it has doubled production capacity to 2 billion doses/year, while Sinopharm said it can produce 3 billion doses/year. From the beginning of the year to the end of May, Sinovac produced 540 million doses of the COVID-19 vaccine. Government support is crucial for vaccine manufacturers at every stage. Sinopharm said that right from the start of the vaccine research, it had borrowed a laboratory at a government research center. Chinese vaccine companies largely do not depend on imported products in the production process, so the scenario of shortage of raw materials and ingredients like the Serum Institute in India should be avoided. As of June 4, China had 91,194 cases of COVID-19, of which 4,636 died.

The WHO Independent Panel of Experts recommends the use of Sinovac vaccine for people over 18 years of age. The evaluation data show that this vaccine is effective in protection in the elderly. Sinovac is the second Chinese vaccine approved by WHO for emergency use. (Photo: Reuters) WHO’s decision was made based on a review of the latest clinical data on the safety and efficacy of Sinovac’s vaccine as well as the company’s manufacturing practices. On May 5, the WHO technical advisory group met, reviewed and evaluated the Sinovac vaccine. WHO Director-General Tedros Adhanom Ghebreyesus said that Sinovac vaccine is safe and effective, emphasizing that it does not require a high level of vaccine preservation, suitable for low-income countries. “Now it’s important to get these life-saving tools quickly into the hands of those who need them.” , the head of WHO said. Sinovac is the second Chinese vaccine approved by WHO for emergency use. On May 7, the Sinopharm vaccine became the first vaccine not from a Western pharmaceutical company to be approved by the WHO. Meanwhile, China’s third vaccine, manufactured by CanSino Biologics, has also submitted clinical trial data. However, WHO has not yet scheduled an assessment. As of the end of May, Sinovac pharmaceutical company has supplied more than 600 million doses inside and outside China, of which more than 430 million doses have been used.

AstraZeneca’s COVID-19 Vaccine. Photo: VNA broadcast Due to the complexity and urgency of the situation, the provision of vaccines individually to each organization is a challenge, the institute’s announcement noted. We urge all organizations and individuals to access vaccines through public agencies and the private health care system. ”| In addition, from July next, the country can increase production of vaccine AstraZeneca to 100 million doses / month, significantly increased from the current 60-70 million doses per month. However, this production growth milestone is two months later than originally intended. The same day, Prime Minister Thailand Prayut Chan-o-cha said the country will seek to buy about 35 million additional doses of COVID-19 vaccine from two or three other manufacturers, in addition to the 65 million doses already ordered. Prime Minister Prayut Chan-o-cha said this would complement the government’s purchase of 65 million doses of vaccine from two manufacturers, AstraZeneca and Sinovac Biotech, according to a Vietnam News Agency correspondent in Bangkok. Of the 35 million doses of the new vaccine, 10-15 million will be bought by the private sector to inject their employees and this will save the government money. Thailand started its vaccination campaign on February 28 with priority given to high-risk people who are health professionals and those in close contact with patients. The country’s vaccination campaign will initially rely on imported vaccines developed by China-based company Sinovac Biotech and will then use the vaccine AstraZeneca contracted by the company Siam Bioscience to make domestically for injection. vaccinated for about 35 million people. As of April 20, more than 2.1 million doses of COVID-19 vaccine, including 117,000 doses of AstraZeneca vaccine, arrived in Thailand. To date, Thailand has received a total of 712,610 doses of the COVID-19 vaccine.